−363 KRW
−9.68 B KRW
6.97 B KRW
15.75 M
About GENINUS INC.
Sector
Industry
CEO
Woong-Yang Park
Website
Headquarters
Seoul
Founded
2018
ISIN
KR7389030008
FIGI
BBG012PLRTX1
GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company was founded on April 20, 2018 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 389030 is 1,430 KRW — it has decreased by −2.39% in the past 24 hours. Watch GENINUS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENINUS INC. stocks are traded under the ticker 389030.
389030 stock has fallen by −4.86% compared to the previous week, the month change is a 2.58% rise, over the last year GENINUS INC. has showed a −40.17% decrease.
389030 reached its all-time high on Nov 8, 2021 with the price of 6,483 KRW, and its all-time low was 1,209 KRW and was reached on Aug 5, 2024. View more price dynamics on 389030 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
389030 stock is 5.24% volatile and has beta coefficient of 1.16. Track GENINUS INC. stock price on the chart and check out the list of the most volatile stocks — is GENINUS INC. there?
Today GENINUS INC. has the market capitalization of 47.69 B, it has increased by 0.13% over the last week.
Yes, you can track GENINUS INC. financials in yearly and quarterly reports right on TradingView.
389030 net income for the last quarter is −2.00 B KRW, while the quarter before that showed −3.91 B KRW of net income which accounts for 48.99% change. Track more GENINUS INC. financial stats to get the full picture.
No, 389030 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 95.00 employees. See our rating of the largest employees — is GENINUS INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENINUS INC. EBITDA is −9.65 B KRW, and current EBITDA margin is −114.37%. See more stats in GENINUS INC. financial statements.
Like other stocks, 389030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENINUS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENINUS INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENINUS INC. stock shows the sell signal. See more of GENINUS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.